Clinical Trial Update: Atorvastatin to Treat Pulmonary Sarcoidosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating atorvastatin for pulmonary sarcoidosis has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Sarcoidosis
• Sarcoidosis

Drugs mentioned

• Lipitor (atorvastatin)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Sarcoidosis, Pulmonary | Phase 2 | Status: COMPLETED | Results posted: 2016-08-12